Author: GlobeNewswire

TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone”…

LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) — Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a…

TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology…

LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a…

BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a…

NEW YORK and WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company…

Abivax Presents First Half 2025 Financial Results PARIS, France, September 8, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris:…

GARDEN CITY, N.Y., Sept. 08, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a…

Persephone First-of-Its-Kind Infant Synbiotic In just over a month, 10,000 parents and caregivers joined the waitlist for Persephone’s science-driven synbiotic…

TIGARD, Ore., Sept. 08, 2025 (GLOBE NEWSWIRE) — Go North Hemp, a U.S. wholesale supplier of hemp-derived ingredients, today announced…